HealthEquity (HQY) vs Privia Health Group (PRVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HealthEquity (HQY) has outperformed Privia Health Group (PRVA) over the past year, gaining 1.0% versus a loss of 17.7%. Over five years, HQY leads with a +47.3% price change compared with -14.1% for PRVA. HealthEquity is the larger company by market cap ($7.70 billion vs $2.58 billion), about 3.0 times the size, while Privia Health Group is growing revenue faster (+22.3% vs +9.5%).
On valuation, HealthEquity trades at a lower forward P/E (16.9x vs 19.0x for Privia Health Group). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus 1.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQY | PRVA |
|---|---|---|
| Share price | $93.05 | $20.19 |
| Market cap | $7.70B | $2.58B |
| 1-day change | +1.25% | -0.54% |
| YTD return | +1.57% | -14.85% |
| 1-year return | +1.04% | -17.69% |
| 5-year return | +47.35% | -14.12% |
| P/E ratio (TTM) | 33.59 | 96.14 |
| Forward P/E | 16.92 | 18.99 |
| EPS (TTM) | $2.77 | $0.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.31B | $2.12B |
| Revenue growth (YoY) | +9.47% | +22.26% |
| Net income (latest FY) | $215.20M | $22.92M |
| Gross margin | 69.52% | — |
| Operating margin | 24.55% | 1.61% |
| Net margin | 16.38% | 1.08% |
| 52-week high | $107.62 | $28.82 |
| 52-week low | $72.76 | $18.92 |
| Distance from 52-week high | -13.54% | -29.94% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +28.24% | +55.87% |
| Average volume | 841.36K | 1.24M |
| Shares outstanding | 82.72M | 127.73M |
| Employees | 2,814 | 1,226 |
| Sector | Consumer Discretionary | Health Care |
| Industry | Business Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HealthEquity is about 3.0 times larger than Privia Health Group by market value ($7.70B vs $2.58B).
- HQY has outperformed PRVA by 18.7 percentage points over the past year.
- Privia Health Group trades at a higher earnings multiple (96.1x vs 33.6x trailing P/E).
- HealthEquity is more profitable, keeping 16.4 cents of every revenue dollar as net income versus 1.1 cents for Privia Health Group.
- Privia Health Group grew revenue faster in its latest fiscal year (+22.26% vs +9.47%).
- The two companies sit in different sectors: HealthEquity in Consumer Discretionary and Privia Health Group in Health Care.
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
HQY vs PRVA FAQ
Which is bigger, HealthEquity or Privia Health Group?
HealthEquity (HQY) is larger, with a market capitalization of $7.70B compared with $2.58B for Privia Health Group (PRVA).
Which stock has performed better over the past year, HQY or PRVA?
HQY returned +1.04% over the past 12 months, compared with -17.69% for PRVA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HQY or PRVA?
HQY has the lower trailing P/E at 33.6, versus 96.1 for PRVA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are HealthEquity and Privia Health Group in the same industry?
No. HealthEquity is in the Consumer Discretionary sector, while Privia Health Group is in Health Care.